Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.3390/NANO8120985 | ||||
| Año | 2018 | ||||
| Tipo | artículo de investigación |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
The inclusion compound (IC) of cyclodextrin (CD) containing the antitumor drug Methotrexate (MTX) as a guest molecule was obtained to increase the solubility of MTX and decrease its inherent toxic effects in nonspecific cells. The IC was conjugated with gold nanoparticles (AuNPs), obtained by a chemical method, creating a ternary intelligent delivery system for MTX molecules, based on the plasmonic properties of the AuNPs. Irradiation of the ternary system, with a laser wavelength tunable with the corresponding surface plasmon of AuNPs, causes local energy dissipation, producing the controlled release of the guest from CD cavities. Finally, cell viability was evaluated using MTS assays for beta-CD/MTX and AuNPs + beta-CD/MTX samples, with and without irradiation, against HeLa tumor cells. The irradiated sample of the ternary system AuNPs + beta-CD/MTX produced a diminution in cell viability attributed to the photothermal release of MTX.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | SILVA-GONZALEZ, NATALY ROXANA | Mujer |
Universidad de Chile - Chile
Universidad de Santiago de Chile - Chile |
| 2 | RIVEROS-SALVATIERRA, ANA LUISA | Hombre |
Universidad de Chile - Chile
|
| 3 | RADIC-FOSCINO, DEODATO | Hombre |
Universidad de Chile - Chile
|
| 4 | LANG-PONTONY, ERIKA PATRICIA | Mujer |
Universidad de Chile - Chile
|
| 5 | CHORNIK-ABERBUCH, BORIS | Hombre |
Universidad de Chile - Chile
|
| 6 | GUERRERO-RIVERA, SIMON JUAN | Hombre |
Universidad de Chile - Chile
|
| 7 | Samitier, Josep | Hombre |
Barcelona Inst Sci & Technol - España
Ctr Invest Biomed Red Bioingn Biomat & Nanomed CI - España Univ Barcelona - España Instituto de Bioingeniería de Cataluña - España CIBER Bioingenieria, Biomateriales y Nanomedicina - España Universitat de Barcelona - España Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina - España |
| 8 | JARA-VERGARA, PAUL SEBASTIAN | Hombre |
Universidad de Chile - Chile
|
| 9 | KOGAN-BOCIAN, MARCELO JAVIER | Hombre |
Universidad de Chile - Chile
|
| Fuente |
|---|
| FONDECYT |
| FONDAP |
| FONDECYT Postdoctoral |
| MECESUP |
| Fondo Nacional de Desarrollo Científico y Tecnológico |
| European Regional Development Fund |
| Universidad de Santiago de Chile |
| Ministerio de Ciencia e Innovación |
| Instituto de Salud Carlos III |
| Center for International Business Education and Research, University of Illinois at Urbana-Champaign |
| Consolider Program |
| Commission for Universities and Research of the Department of Innovation, Universities, and Enterprise of the Generalitat de Catalunya |
| Scholarships Conicyt N.S. Grand, BECAS CHILE Convocatoria 2011 |
| VI National R&D&i Plan 2008-2011 |
| Iniciativa Ingenio 2010 |
| laboratory NMR USACH (Bruker Avance) |
| Generalitat de Catalunya through the CERCA program |
| MIND - Spanish Ministry of Science and Innovation (MICINN) under the National Program for the internationalization of RD |
| Spanish Ministry of Economy, Industry and Competitiveness through the Centro de Excelencia Severo Ochoa Award |
| CIBER Actions |
| Agradecimiento |
|---|
| The authors would like to express their gratitude for the support from the laboratory NMR USACH (Bruker Avance 400 MHz). We thank the Kampar oncology laboratory for the donation of the Methotrexate drug. Fondecyt 1170929, 1171611, and 1160114. Scholarships Conicyt N.S. Grand AT-24121127, BECAS CHILE Convocatoria 2011. Fondecyt Postdoctoral 3150271. Fondap 15130011. MECESUP 0811. This work was partially supported by the MIND funded by the Spanish Ministry of Science and Innovation (MICINN) under the National Program for the internationalization of R&D, the Spanish Ministry of Economy, Industry and Competitiveness through the Centro de Excelencia Severo Ochoa Award and by the Generalitat de Catalunya through the CERCA program. CIBER-BBN is an initiative funded by the VI National R&D&i Plan 2008-2011, Iniciativa Ingenio 2010, Consolider Program, CIBER Actions and financed by the Instituto de Salud Carlos III with assistance from the European Regional Development Fund. The Nanobioengineering group has support from the Commission for Universities and Research of the Department of Innovation, Universities, and Enterprise of the Generalitat de Catalunya (2014 SGR 1442). |
| The authors would like to express their gratitude for the support from the laboratory NMR USACH (Bruker Avance 400 MHz). We thank the Kampar oncology laboratory for the donation of the Methotrexate drug. Fondecyt 1170929, 1171611, and 1160114. Scholarships Conicyt N.S. Grand AT-24121127, BECAS CHILE Convocatoria 2011. Fondecyt Postdoctoral 3150271. Fondap 15130011. MECESUP 0811. This work was partially supported by the MIND funded by the Spanish Ministry of Science and Innovation (MICINN) under the National Program for the internationalization of R&D, the Spanish Ministry of Economy, Industry and Competitiveness through the Centro de Excelencia Severo Ochoa Award and by the Generalitat de Catalunya through the CERCA program. CIBER-BBN is an initiative funded by the VI National R&D&i Plan 2008–2011, Iniciativa Ingenio 2010, Consolider Program, CIBER Actions and financed by the Instituto de Salud Carlos III with assistance from the European Regional Development Fund. The Nanobioengineering group has support from the Commission for Universities and Research of the Department of Innovation, Universities, and Enterprise of the Generalitat de Catalunya (2014 SGR 1442). |